or Try an Advanced Search...

    Immune Disorders Stocks List

    Symbol Grade Name % Change
    BNTX C BioNTech SE -0.43
    BIIB C Biogen Idec Inc. -1.68
    NRIX D Nurix Therapeutics, Inc. -1.54
    STRO D Sutro Biopharma, Inc. -2.99
    CGEN D Compugen Ltd. 6.90
    IMAB D I-Mab 0.28
    CUE D Cue Biopharma, Inc. 0.80
    BAX F Baxter International Inc. -1.63
    PLX F Protalix BioTherapeutics, Inc. 0.00
    VCNX F Vaccinex, Inc. -1.82
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies
    Related Stock Lists: Allergies Allergy Autoimmune Disorders Autoimmunity Biomarkers Biotechnology Clinical Medicine Diagnostic Devices Disease Drug Discovery Immunology In Vitro In Vitro Diagnostic Device Infectious Diseases Medicine Vaccines

    Related ETFs - A few ETFs which own one or more of the above listed Immune Disorders stocks.

    Symbol Grade Name Weight
    GERM B ETFMG Treatments Testing and Advancements ETF 6.09
    FBT D First Trust Amex Biotech Index Fund 3.39
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.32
    GNOM D Global X Genomics & Biotechnology ETF 3.3
    BBH B Market Vectors Biotech ETF 2.18
    View all Immune Disorders ETFs...
    Compare ETFs
    Compare FBT to BBH Compare FBT to IDNA Compare GERM to BBH

        Immune Disorders Stocks Recent News

        Date Stock Title
        May 21 BIIB Why Biogen Inc. (BIIB) is a Top Momentum Stock for the Long-Term
        May 21 BNTX BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
        May 20 NRIX Nurix Therapeutics announces Julia P. Gregory as new board Chair
        May 20 NRIX Nurix Therapeutics Announces Board Chair Transition
        May 20 CGEN Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript
        May 20 NRIX Nurix Therapeutics (NRIX) Moves 7.7% Higher: Will This Strength Last?
        May 20 CGEN Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
        May 20 CGEN Compugen GAAP EPS of -$0.08 beats by $0.03, revenue of $2.56M beats by $1.35M
        May 20 CGEN Compugen Reports First Quarter 2024 Results
        May 18 BNTX Q1 2024 Autolus Therapeutics PLC Earnings Call
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 BNTX European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
        May 17 CGEN Compugen Q1 2024 Earnings Preview
        May 17 BNTX Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 BNTX Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 BNTX BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies
        Related Stock Lists: Allergies Allergy Autoimmune Disorders Autoimmunity Biomarkers Biotechnology Clinical Medicine Diagnostic Devices Disease Drug Discovery Immunology In Vitro In Vitro Diagnostic Device Infectious Diseases Medicine Vaccines
        Immune Disorders

        Immune disorders are conditions that occur when the body's immune system is not functioning properly. These disorders can cause the body to be more susceptible to infections, or can cause the body to attack its own cells and tissues. Examples of immune disorders include allergies, asthma, autoimmune diseases, and immunodeficiency disorders.

        Browse All Tags